Kulkarni AA - Search Results

1

Antiviral activities of selected antimalarials against dengue virus type 2 and Zika virus.

Balasubramanian A, Teramoto T, Kulkarni AA, Bhattacharjee AK, Padmanabhan R. Balasubramanian A, et al. Among authors: kulkarni aa. Antiviral Res. 2017 Jan;137:141-150. doi: 10.1016/j.antiviral.2016.11.015. Epub 2016 Nov 23. Antiviral Res. 2017. PMID: 27889529

2

Inhibition of dengue virus by curcuminoids.

Balasubramanian A, Pilankatta R, Teramoto T, Sajith AM, Nwulia E, Kulkarni A, Padmanabhan R. Balasubramanian A, et al. Antiviral Res. 2019 Feb;162:71-78. doi: 10.1016/j.antiviral.2018.12.002. Epub 2018 Dec 6. Antiviral Res. 2019. PMID: 30529358 Free PMC article.

3

Protein Phosphatase 1-Targeting Small-Molecule C31 Inhibits Ebola Virus Replication.

Ammosova T, Pietzsch CA, Saygideger Y, Ilatovsky A, Lin X, Ivanov A, Kumari N, Jerebtsova M, Kulkarni A, Petukhov M, Üren A, Bukreyev A, Nekhai S. Ammosova T, et al. J Infect Dis. 2018 Nov 22;218(suppl_5):S627-S635. doi: 10.1093/infdis/jiy422. J Infect Dis. 2018. PMID: 30169869 Free PMC article.

4

Inhibition of HIV-1 by curcumin A, a novel curcumin analog.

Kumari N, Kulkarni AA, Lin X, McLean C, Ammosova T, Ivanov A, Hipolito M, Nekhai S, Nwulia E. Kumari N, et al. Among authors: kulkarni aa. Drug Des Devel Ther. 2015 Sep 3;9:5051-60. doi: 10.2147/DDDT.S86558. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26366056 Free PMC article.

5

1E7-03, a low MW compound targeting host protein phosphatase-1, inhibits HIV-1 transcription.

Ammosova T, Platonov M, Ivanov A, Kont YS, Kumari N, Kehn-Hall K, Jerebtsova M, Kulkarni AA, Uren A, Kovalskyy D, Nekhai S. Ammosova T, et al. Among authors: kulkarni aa. Br J Pharmacol. 2014 Nov;171(22):5059-75. doi: 10.1111/bph.12863. Br J Pharmacol. 2014. PMID: 25073485 Free PMC article.

6

Inhibition of HIV-1 infection in humanized mice and metabolic stability of protein phosphatase-1-targeting small molecule 1E7-03.

Lin X, Kumari N, DeMarino C, Kont YS, Ammosova T, Kulkarni A, Jerebtsova M, Vazquez-Meves G, Ivanov A, Dmytro K, Üren A, Kashanchi F, Nekhai S. Lin X, et al. Oncotarget. 2017 Aug 7;8(44):76749-76769. doi: 10.18632/oncotarget.19999. eCollection 2017 Sep 29. Oncotarget. 2017. PMID: 29100346 Free PMC article.

7

Structural Optimization of 2,3-Dihydro-1H-cyclopenta[b]quinolines Targeting the Noncatalytic RVxF Site of Protein Phosphatase 1 for HIV-1 Inhibition.

Lin X, Sajith AM, Wang S, Kumari N, Choy MS, Ahmad A, Cadet DR, Gu X, Ivanov AI, Peti W, Kulkarni A, Nekhai S. Lin X, et al. ACS Infect Dis. 2020 Dec 11;6(12):3190-3211. doi: 10.1021/acsinfecdis.0c00511. Epub 2020 Dec 1. ACS Infect Dis. 2020. PMID: 33258581 Free PMC article.

8

Design, synthesis, and biological evaluation of inhibitors of the NADPH oxidase, Nox4.

Xu Q, Kulkarni AA, Sajith AM, Hussein D, Brown D, Güner OF, Reddy MD, Watkins EB, Lassègue B, Griendling KK, Bowen JP. Xu Q, et al. Among authors: kulkarni aa. Bioorg Med Chem. 2018 Mar 1;26(5):989-998. doi: 10.1016/j.bmc.2017.12.023. Epub 2017 Dec 17. Bioorg Med Chem. 2018. PMID: 29426628 Free PMC article.

9

Design, synthesis, and screening of sulfonylurea-derived NLRP3 inflammasome inhibitors.

Kulkarni AA, Sajith AM, Duarte TT, Tena A, Spencer CT, Bowen JP. Kulkarni AA, et al. Med Chem Res. 2020;29(1):126-135. doi: 10.1007/s00044-019-02466-7. Epub 2019 Nov 14. Med Chem Res. 2020. PMID: 32435125 Free PMC article.

10

Targeting NLRP3 signaling by a novel-designed sulfonylurea compound for inhibition of microglial inflammation.

Zhang C, Sajith AM, Xu X, Jiang J, Phillip Bowen J, Kulkarni A, Hao J. Zhang C, et al. Bioorg Med Chem. 2022 Mar 15;58:116645. doi: 10.1016/j.bmc.2022.116645. Epub 2022 Jan 31. Bioorg Med Chem. 2022. PMID: 35151118 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

162 results

Search Page